Wordt geladen...
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
Chronic hepatitis C virus (HCV) infection impacts approximately 71 million people and approximately 400,000 deaths are attributed to HCV-related liver disease annually worldwide. Mainstay of treatment for over 25 years has been pegylated interferon until the advent of protease inhibitors, which has...
Bewaard in:
| Gepubliceerd in: | Hepat Med |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942172/ https://ncbi.nlm.nih.gov/pubmed/29765256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S130103 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|